EC
DGX icon

EntryPoint Capital’s Quest Diagnostics DGX Stock Holding History

EntryPoint Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-872
Closed -$116K – 1059
2024
Q1 		$116K Buy
872
+832
+2,080% +$108K 0.1% 332
2023
Q4 		$5.51K Buy
+40
New +$5.26K 0.01% 1210

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EntryPoint Capital's DGX Position: Q2 2024 in Review

EntryPoint Capital sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 872 shares — an estimated $116K sold.

EntryPoint Capital first reported a position in DGX in Q4 2023 and held it in 2 quarters. The position peaked at $116K in Q1 2024. 837 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • EntryPoint Capital reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • EntryPoint Capital sold 872 Quest Diagnostics shares in Q2 2024, an estimated $116K.
  • EntryPoint Capital first reported a position in Quest Diagnostics in Q4 2023 and held it in 2 quarters.
  • EntryPoint Capital's Quest Diagnostics position peaked at $116K in Q1 2024.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.